Abstract
Understanding the origins and developmental trajectory of innate lymphoid cell (ILC) progenitors has been of substantial interest to the fields of ILC biology and immunology. While mature ILC are rare lymphocytes, ILC progenitors represent an even smaller fraction of cells, providing additional challenges in studying them. Moreover, though the approaches to studying these cells are conceptually straightforward, the technical nuances that underlie them can substantially affect the quality of the data. Herein, we provide a detailed protocol for assessing the frequency of ILC progenitors in the bone marrow, their phenotype, and their potential to develop into mature ILC. These methods make up the foundation of in vivo investigations into ILC development, and we hope these thorough protocols and associated notes facilitate additional, high-quality inquiries into this fascinating field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cherrier DE, Serafini N, Di Santo JP (2018) Innate lymphoid cell development: a T cell perspective. Immunity 48:1091–1103
Stier MT, Peebles RS (2017) Innate lymphoid cells and allergic disease. Ann Allergy Asthma Immunol 119:480–488
Ghaedi M, Steer CA, Martinez-Gonzalez I et al (2016) Common-lymphoid-progenitor-independent pathways of innate and T lymphocyte development. Cell Rep 15:471–480
Kondo M, Weissman IL, Akashi K (1997) Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661–672
Wong SH, Walker JA, Jolin HE et al (2012) Transcription factor RORα is critical for nuocyte development. Nat Immunol 13:229–236
Hoyler T, Klose CSN, Souabni A et al (2012) The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37:634–648
Klose CSN, Flach M, Möhle L et al (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157:340–356
Satoh-Takayama N, Lesjean-Pottier S, Vieira P et al (2010) IL-7 and IL-15 independently program the differentiation of intestinal CD3−NKp46+ cell subsets from Id2-dependent precursors. J Exp Med 207:273–280
Moro K, Yamada T, Tanabe M et al (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463:540–544
Yang Q, Li F, Harly C et al (2015) TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nat Immunol 16:1044–1050
Constantinides MG, McDonald BD, Verhoef PA et al (2014) A committed precursor to innate lymphoid cells. Nature 508:397
Yu Y, Tsang JCH, Wang C et al (2016) Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its development pathway. Nature 539:102–106
Zook EC, Ramirez K, Guo X et al (2016) The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2. J Exp Med 213:687–696
Stier MT, Zhang J, Goleniewska K et al (2018) IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow. J Exp Med 215:263–281
de Kleer IM, Kool M, de Bruijn MJW et al (2016) Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung. Immunity 45:1285–1298
Saluzzo S, Gorki A-D, Rana BMJ et al (2017) First-breath-induced type 2 pathways shape the lung immune environment. Cell Rep 18:1893–1905
Steer CA, Martinez-Gonzalez I, Ghaedi M et al (2017) Group 2 innate lymphoid cell activation in the neonatal lung drives type 2 immunity and allergen sensitization. J Allergy Clin Immunol 140:593
Karta MR, Rosenthal PS, Beppu A et al (2018) β2 integrins rather than β1 integrins mediate Alternaria-induced ILC2 trafficking to the lung. J Allergy Clin Immunol 141(1):329–338.e12
Huang Y, Mao K, Chen X et al (2018) S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359:114–119
Kim MH, Taparowsky EJ, Kim CH (2015) Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut. Immunity 43:107–119
Gasteiger G, Fan X, Dikiy S et al (2015) Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350:981–985
O’Sullivan TE, Rapp M, Fan X et al (2016) Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 45:428–441
Nussbaum JC, Van Dyken SJ, von Moltke J et al (2013) Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502:245–248
Schneider C, Lee J, Koga S et al (2019) Tissue-resident group 2 innate lymphoid cells differentiate by layered ontogeny and in situ perinatal priming. Immunity 50:1425
Bando JK, Liang H-E, Locksley RM (2015) Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine. Nat Immunol 16:153–160
Koga S, Hozumi K, Hirano K et al (2018) Peripheral PDGFRα+ gp38+ mesenchymal cells support the differentiation of fetal liver-derived ILC2. J Exp Med 215:1609–1626
Xu W, Cherrier DE, Chea S et al (2019) An Id2RFP-reporter mouse redefines innate lymphoid cell precursor potentials. Immunity 50:1054–1068.e3
Yu X, Wang Y, Deng M et al (2014) The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife 3. https://doi.org/10.7554/eLife.04406
Maecker HT, Trotter J (2006) Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69A:1037–1042
Acknowledgments
Optimization of the protocols described herein was supported by the National Institutes of Health (R01AI145265, R01AI124456, R01AI111820, R21AI145397, and U19AI095227) and the US Department of Veterans Affairs (I01BX004299).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Stier, M.T., Peebles, R.S. (2020). Protocols for Studying Murine ILC Development. In: Amarnath, S. (eds) Innate Lymphoid Cells . Methods in Molecular Biology, vol 2121. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0338-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0338-3_2
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0337-6
Online ISBN: 978-1-0716-0338-3
eBook Packages: Springer Protocols